CircSMARCA5 terminates SMARCA5 transcription at exon 15 to reduce its expression, thereby inhibiting SMARCA5-mediated DNA damage repair and cisplatin resistance in breast cancer (BC)[14]. The gene discussed is SMARCA5; the disease is breast carcinoma.